Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
about
ClC-1 chloride channels: state-of-the-art research and future challenges.Clinical, pathological and genetic characteristics of a pedigree with myotonic dystrophy type 1.Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1.Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease.Clinical characteristics of pregnancies complicated by congenital myotonic dystrophy.Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.Effect on lung function of mounthpiece ventilation in Steinert disease. A case report.In vivo assessment of muscle membrane properties in myotonic dystrophy.Surgical Orthodontic Treatment of a Patient Affected by Type 1 Myotonic Dystrophy (Steinert Syndrome).Early onset posterior subscapular cataract in a series of myotonic dystrophy type 2 patients.Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.Core Clinical Phenotypes in Myotonic Dystrophies.
P2860
Q35541006-17F6CAB3-2715-4478-9DCA-9580A92B4584Q36335776-5571580C-A6FE-4EE7-852F-403F510121FFQ37459974-64DA06F4-997B-4B0C-9CD2-DCA758425ED0Q37529679-03EC39F9-2803-492C-B7F3-F90EC7F76F93Q38632916-76E60700-FF3B-4B8B-AB53-A3C59807ED00Q38812196-ACE67D15-3ED7-4D52-93F2-914F87B9F14CQ41078186-7349CFA8-0437-47BF-BC06-62DF8BF3B058Q41878069-8A5DF7B8-EBF4-4B9B-A480-5BB0398DD331Q42204225-B4E030B8-81D9-49A6-8C19-397CCF7F1952Q50006110-2758FE12-7482-4451-A6A8-99BD48E85550Q54982478-15D745A0-8D05-4A57-ADA7-5C0FDD68A461Q55189250-C8E0A6A6-A72D-4286-AA60-440F8EDB44F7
P2860
Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
@en
type
label
Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
@en
prefLabel
Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
@en
P2860
P1433
P1476
Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
@en
P2093
Giovanni Meola
P2860
P304
P5008
P577
2013-12-01T00:00:00Z